Literature DB >> 1701016

Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner.

W R Huckle1, C A Prokop, R C Dy, B Herman, S Earp.   

Abstract

Cellular responses to epidermal growth factor (EGF) are dependent on the tyrosine-specific protein kinase activity of the cell-surface EGF receptor. Previous studies using WB rat liver epithelial cells have detected at least 10 proteins whose phosphotyrosine (P-Tyr) content is increased by EGF. In this study, we have examined alternate modes of activating tyrosine phosphorylation. Treatment of WB cells with hormones linked to Ca2+ mobilization and protein kinase C (PKC) activation, including angiotensin II, [Arg8]vasopressin, or epinephrine, stimulated rapid (less than or equal to 15-s) and transient increases in the P-Tyr content of several proteins (p120/125, p75/78, and p66). These proteins, detected by anti-P-Tyr immunoblotting, were similar in molecular weight to a subset of EGF-sensitive P-Tyr-containing proteins (P-Tyr-proteins). The increased P-Tyr content was confirmed by [32P]phosphoamino acid analysis of proteins recovered by anti-P-Tyr immunoprecipitation. Elevating intracellular [Ca2+] with the ionophore A23187 or ionomycin or with the tumor promoter thapsigargin mimicked the effects of hormones on tyrosine phosphorylation, whereas treatment with a PKC-activating phorbol ester did not. In addition, responses to angiotensin II were not diminished in PKC-depleted cells. Ca2+ mobilization, measured by fura-2 fluorescence, was coincident with the increase in tyrosine phosphorylation in response to angiotensin II or thapsigargin. Loading cells with the intracellular Ca2+ chelator bis-(o-aminophenoxy)ethane-N ,N ,N' , N'-tetraacetic acid (BAPTA) inhibited the appearance of all P-Tyr-proteins in response to angiotensin II, thapsigargin, or ionophores, as well as two EGF-stimulated P-Tyr-proteins. The majority of EGF-stimulated P-Tyr-proteins were not affected by BAPTA. These studies indicate that angiotensin II can alter protein-tyrosine phosphorylation in a manner that is secondary to, and apparently dependent on, Ca2+ mobilization. Thus, ligands such as EGF and angiotensin II, which act through distinct types of receptors, may activate secondary pathways involving tyrosine phosphorylation. These results also raise the possibility that certain growth-promoting effects of Ca2+ -mobilizing agents such as angiotensin II may be mediated via tyrosine phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701016      PMCID: PMC362904          DOI: 10.1128/mcb.10.12.6290-6298.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  81 in total

Review 1.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Two related but distinct forms of the Mr 36,000 tyrosine kinase substrate (calpactin) that interact with phospholipid and actin in a Ca2+-dependent manner.

Authors:  J Glenney
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Phosphorylation of the transforming protein of Rous sarcoma virus: direct demonstration of phosphorylation of serine 17 and identification of an additional site of tyrosine phosphorylation in p60v-src of Prague Rous sarcoma virus.

Authors:  T Patschinsky; T Hunter; B M Sefton
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

4.  Amiloride sensitive activation of S6 kinase by angiotensin II in cultured vascular smooth muscle cells.

Authors:  T Scott-Burden; T J Resink; U Baur; M Bürgin; F R Bühler
Journal:  Biochem Biophys Res Commun       Date:  1988-02-29       Impact factor: 3.575

5.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Authors:  A Ullrich; J R Bell; E Y Chen; R Herrera; L M Petruzzelli; T J Dull; A Gray; L Coussens; Y C Liao; M Tsubokawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

6.  Lack of association of epidermal growth factor-, insulin-, and serum-induced mitogenesis with stimulation of phosphoinositide degradation in BALB/c 3T3 fibroblasts.

Authors:  J M Besterman; S P Watson; P Cuatrecasas
Journal:  J Biol Chem       Date:  1986-01-15       Impact factor: 5.157

7.  Activation of 45Ca2+ influx and 22Na+/H+ exchange by epidermal growth factor and vanadate in A431 cells is independent of phosphatidylinositol turnover and is inhibited by phorbol ester and diacylglycerol.

Authors:  I G Macara
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

8.  The effects of epidermal growth factor and the state of confluence on enzymatic activities of cultured rat liver epithelial cells.

Authors:  M S Tsao; H S Earp; J W Grisham
Journal:  J Cell Physiol       Date:  1986-02       Impact factor: 6.384

9.  Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane.

Authors:  H Takemura; A R Hughes; O Thastrup; J W Putney
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

10.  Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes.

Authors:  R Bravo; J Burckhardt; T Curran; R Müller
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  21 in total

1.  Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells.

Authors:  S Offermanns; R Seifert; J W Metzger; G Jung; A Lieberknecht; U Schmidt; G Schultz
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Analysis of the fibroblast transformation potential of GTPase-deficient gip2 oncogenes.

Authors:  S K Gupta; C Gallego; J M Lowndes; C M Pleiman; C Sable; B J Eisfelder; G L Johnson
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

Review 3.  The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth.

Authors:  B Schieffer; K E Bernstein; M B Marrero
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

4.  Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cells.

Authors:  Sivaramakrishna Koganti; Russell Snyder; Thomas Thekkumkara
Journal:  Gend Med       Date:  2012-02-25

5.  Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway.

Authors:  X Li; J W Lee; L M Graves; H S Earp
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

Review 6.  Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells.

Authors:  S Meloche; S Pelletier; M J Servant
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 7.  Angiotensin II-mediated signal transduction pathways.

Authors:  Yuji Saito; Bradford C Berk
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 8.  Protein tyrosine phosphorylation in cardiovascular system.

Authors:  A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

9.  Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.

Authors:  H Weber; D S Taylor; C J Molloy
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II.

Authors:  W R Huckle; R C Dy; H S Earp
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.